“Alert: Medication Quality Issue Uncovered via GeM Portal Procurement”

A recent discovery has raised concerns regarding the quality of pharmaceuticals obtained through the Government e-Marketplace (GeM) Portal. The Drug Testing Laboratory has flagged a batch of Ciprofloxacin Hydrochloride TP 500 tablets from Karnataka Antibiotics & Pharmaceuticals Limited as “Not of Standard Quality.” The issue, concerning non-compliance with dissolution tests as per the Indian Pharmacopoeia, prompts immediate action. Entities that procured this batch are urged to halt its usage, cease payment, and report the incident on the GeM Portal for further action. This notice, sanctioned by the corporation, underscores the criticality of quality assurance in healthcare procurement. This notification was published on 13/05/2024.